Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes

详细信息    查看全文

• 作者：Xiao-Yong Man (1)
  Wei Li (1)
  Jia-Qi Chen (1)
  Jiong Zhou (1)
  Lilla Landeck (2)
  Kai-Hong Zhang (3)
  Zhen Mu (3)
  Chun-Ming Li (1)
  Sui-Qing Cai (1)
  Min Zheng (1)
  
• 关键词：Glucocorticoid receptor ; Nuclear translocation ; Psoriasis ; Keratinocyte
• 刊名：Cellular and Molecular Life Sciences (CMLS)
• 出版年：2013
• 出版时间：June 2013
• 年：2013
• 卷：70
• 期：12
• 页码：2205-2220
• 全文大小：2826KB
• 参考文献：1. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med 353:1711-723 CrossRef
  2. Witchel SF, DeFranco DB (2006) Mechanisms of disease: regulation of glucocorticoid and receptor levels—impact on the metabolic syndrome. Nat Clin Pract Endocrinol Metab 2:621-31 CrossRef
  3. Webster JI, Tonelli L, Sternberg EM (2002) Neuroendocrine regulation of immunity. Annu Rev Immunol 20:125-63 CrossRef
  4. Budunova IV, Kowalczyk D, Perez P, Yao YJ, Jorcano JL, Slaga TJ (2003) Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis. Oncogene 22:3279-287 CrossRef
  5. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-73 CrossRef
  6. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-09 CrossRef
  7. Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899-912 CrossRef
  8. Sevilla LM, Latorre V, Sanchis A, Perez P (2012) Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation. J Invest Dermatol. doi:10.1038/jid.2012.281
  9. Perez P (2011) Glucocorticoid receptors, epidermal homeostasis and hair follicle differentiation. Dermatoendocrinol 3:166-74
  10. Yemelyanov A, Czwornog J, Chebotaev D, Karseladze A, Kulevitch E, Yang X, Budunova I (2007) Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 26:1885-896 CrossRef
  11. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435-441 CrossRef
  12. Galigniana MD, Housley PR, DeFranco DB, Pratt WB (1999) Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J Biol Chem 274:16222-6227 CrossRef
  13. Zhou J, Cidlowski JA (2005) The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70:407-17 CrossRef
  14. DeFranco DB, Qi M, Borror KC, Garabedian MJ, Brautigan DL (1991) Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol Endocrinol 5:1215-228 CrossRef
  15. Madan AP, DeFranco DB (1993) Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci USA 90:3588-592 CrossRef
  16. Beato M, Herrlich P, Schutz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-57 CrossRef
  17. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83:835-39 CrossRef
  18. Chrousos GP, Kino T (2005) Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005:pe48
  19. Man XY, Yang XH, Cai SQ, Bu ZY, Zheng M (2008) Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. J Cell Mol Med 12:649-60 CrossRef
  20. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M (2006) Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med 12:127-36 CrossRef
  21. Suzuki K, Bose P, Leong-Quong RY, Fujita DJ, Riabowol K (2010) REAP: a two-minute cell fractionation method. BMC Res Notes 3:294 CrossRef
  22. Hilscherova K, Jones PD, Gracia T, Newsted JL, Zhang X, Sanderson JT, Yu RM, Wu RS, Giesy JP (2004) Assessment of the effects of chemicals on the expression of ten steroidogenic genes in the H295R cell line using real-time PCR. Toxicol Sci 81:78-9 CrossRef
  23. Thiboutot D, Jabara S, McAllister JM, Sivarajah A, Gilliland K, Cong Z, Clawson G (2003) Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol 120:905-14 CrossRef
  24. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-146 CrossRef
  25. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE (1999) Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 141:1054-060 CrossRef
  26. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111:1- CrossRef
  27. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161-68 CrossRef
  28. Detmar M (2004) Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis. J Invest Dermatol 122:xiv–xv
  29. Young HS, Summers AM, Bhushan M, Brenchley PE, Griffiths CE (2004) Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 122:209-15 CrossRef
  30. Abdallah MA, Abdel-Hamid MF, Kotb AM, Mabrouk EA (2009) Serum interferon-gamma is a psoriasis severity and prognostic marker. Cutis 84:163-68
  31. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285:1733-737 CrossRef
  32. Otero MJ, Carrasco L (1984) Action of oligomycin on cultured mammalian cells. Permeabilization to translation inhibitors. Mol Cell Biochem 61:183-91
  33. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182:5836-845 CrossRef
  34. Jordan MA, Himes RH, Wilson L (1985) Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res 45:2741-747
  35. Spokoini R, Kfir-Erenfeld S, Yefenof E, Sionov RV (2010) Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Mol Endocrinol 24:1136-150 CrossRef
  36. Beurel E, Michalek SM, Jope RS (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31:24-1 CrossRef
  37. Espinosa L, Ingles-Esteve J, Aguilera C, Bigas A (2003) Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 278:32227-2235 CrossRef
  38. Roberson ED, Bowcock AM (2010) Psoriasis genetics: breaking the barrier. Trends Genet 26:415-23 CrossRef
  39. Bonifati C, Mussi A, Carducci M, Pittarello A, D’Auria L, Venuti A, Bagnato A, Salani D, Fazio M, Ameglio F (1998) Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 78:22-6 CrossRef
  40. Sato C, Tsuboi R, Shi CM, Rubin JS, Ogawa H (1995) Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J Invest Dermatol 104:958-63 CrossRef
  41. Sun LD, Cheng H, Wang ZX, Zhang AP, Wang PG, Xu JH, Zhu QX, Zhou HS, Ellinghaus E, Zhang FR, Pu XM, Yang XQ, Zhang JZ, Xu AE, Wu RN, Xu LM, Peng L, Helms CA, Ren YQ, Zhang C, Zhang SM, Nair RP, Wang HY, Lin GS, Stuart PE, Fan X, Chen G, Tejasvi T, Li P, Zhu J, Li ZM, Ge HM, Weichenthal M, Ye WZ, Shen SK, Yang BQ, Sun YY, Li SS, Lin Y, Jiang JH, Li CT, Chen RX, Cheng J, Jiang X, Zhang P, Song WM, Tang J, Zhang HQ, Sun L, Cui J, Zhang LJ, Tang B, Huang F, Qin Q, Pei XP, Zhou AM, Shao LM, Liu JL, Zhang FY, Du WD, Franke A, Bowcock AM, Elder JT, Liu JJ, Yang S, Zhang XJ (2010) Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet 42:1005-009 CrossRef
  42. King WJ, Greene GL (1984) Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307:745-47 CrossRef
  43. Welshons WV, Krummel BM, Gorski J (1985) Nuclear localization of unoccupied receptors for glucocorticoids, estrogens, and progesterone in GH3 cells. Endocrinology 117:2140-147 CrossRef
  44. Kemppainen JA, Lane MV, Sar M, Wilson EM (1992) Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 267:968-74
  45. Dauvois S, White R, Parker MG (1993) The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 106:1377-388
  46. Perrot-Applanat M, Logeat F, Groyer-Picard MT, Milgrom E (1985) Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 116:1473-484 CrossRef
  47. Serres M, Viac J, Schmitt D (1996) Glucocorticoid receptor localization in human epidermal cells. Arch Dermatol Res 288:140-46 CrossRef
  48. Chandler VL, Maler BA, Yamamoto KR (1983) DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell 33:489-99 CrossRef
  49. Davies E, MacKenzie SM (2003) Extra-adrenal production of corticosteroids. Clin Exp Pharmacol Physiol 30:437-45 CrossRef
  50. Noti M, Sidler D, Brunner T (2009) Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean? Semin Immunopathol 31:237-48 CrossRef
  51. Noti M, Corazza N, Mueller C, Berger B, Brunner T (2010) TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis. J Exp Med 207:1057-066 CrossRef
  52. Mueller M, Atanasov A, Cima I, Corazza N, Schoonjans K, Brunner T (2007) Differential regulation of glucocorticoid synthesis in murine intestinal epithelial versus adrenocortical cell lines. Endocrinology 148:1445-453 CrossRef
  53. Nickoloff BJ, Xin H, Nestle FO, Qin JZ (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25:568-73 CrossRef
  54. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699-11 CrossRef
  55. Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci USA 106:21264-1269 CrossRef
  56. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM et al (1993) p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833-39 CrossRef
  57. Harrell JM, Murphy PJ, Morishima Y, Chen H, Mansfield JF, Galigniana MD, Pratt WB (2004) Evidence for glucocorticoid receptor transport on microtubules by dynein. J Biol Chem 279:54647-4654 CrossRef
  58. Galigniana MD, Scruggs JL, Herrington J, Welsh MJ, Carter-Su C, Housley PR, Pratt WB (1998) Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol Endocrinol 12:1903-913 CrossRef
  59. Szapary D, Barber T, Dwyer NK, Blanchette-Mackie EJ, Simons SS Jr (1994) Microtubules are not required for glucocorticoid receptor-mediated gene induction. J Steroid Biochem Mol Biol 51:143-48 CrossRef
  60. Vorgias CE, Perides GA, Traub P, Sekeris CE (1988) Colchicine, colcemide and cytochalasin B do not affect translocation of the glucocorticoid hormone-receptor in rat thymocytes or Ehrlich ascites cells. Biosci Rep 8:193-97 CrossRef
  61. Reimer R, Helmbold H, Szalay B, Hagel C, Hohenberg H, Deppert W, Bohn W (2009) Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. PLoS ONE 4:e6084 CrossRef
  62. Glass CK, Saijo K (2010) Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol 10:365-76 CrossRef
  63. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR (1992) Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1114:147-62
  64. Ginger RS, Dalton EC, Ryves WJ, Fukuzawa M, Williams JG, Harwood AJ (2000) Glycogen synthase kinase-3 enhances nuclear export of a dictyostelium STAT protein. EMBO J 19:5483-491 CrossRef
  65. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR (1997) Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-934 CrossRef
  66. Rogatsky I, Waase CL, Garabedian MJ (1998) Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J Biol Chem 273:14315-4321 CrossRef
  67. Nickoloff BJ (2007) Cracking the cytokine code in psoriasis. Nat Med 13:242-44 CrossRef
  68. Blumberg H, Dinh H, Dean C Jr, Trueblood ES, Bailey K, Shows D, Bhagavathula N, Aslam MN, Varani J, Towne JE, Sims JE (2010) IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 185:4354-362 CrossRef
  69. Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127:871-84 CrossRef
  70. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok PY, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41:199-04 CrossRef
  71. Spadaro A, Rinaldi T, Riccieri V, Valesini G, Taccari E (2002) Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis. Ann Rheum Dis 61:174-76 CrossRef
  72. Cancino-Diaz JC, Reyes-Maldonado E, Banuelos-Panuco CA, Jimenez-Zamudio L, Garcia-Latorre E, Leon-Dorantes G, Blancas-Gonzalez F, Paredes-Cabrera G, Cancino-Diaz ME (2002) Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein. J Invest Dermatol 119:1114-120 CrossRef
  73. Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461-67 CrossRef
  74. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suarez-Farinas M, Fuentes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA, Krueger JG (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-194 CrossRef
  75. Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M, Milgrom E (1991) Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J 10:3851-859
  76. Sheu HM, Lee JY, Chai CY, Kuo KW (1997) Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol 136:884-90 CrossRef
  77. du Vivier A, Phillips H, Hehir M (1982) Applications of glucocorticosteroids. The effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis. Arch Dermatol 118:305-08 CrossRef
  78. Carey W, Glazer S, Gottlieb AB, Lebwohl M, Leonardi C, Menter A, Papp K, Rundle AC, Toth D (2006) Relapse, rebound, and psoriasis adverse events: an advisory group report. J Am Acad Dermatol 54:S171-81 CrossRef
  79. Davies L, Karthikeyan N, Lynch JT, Sial EA, Gkourtsa A, Demonacos C, Krstic-Demonacos M (2008) Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function. Mole Endocrinol 22:1331-344 CrossRef
  80. Vandevyver S, Dejager L, Van Bogaert T, Kleyman A, Liu Y, Tuckermann J, Libert C (2012) Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J Clin Invest 122:2130-140 CrossRef
  
• 作者单位：Xiao-Yong Man (1)
  Wei Li (1)
  Jia-Qi Chen (1)
  Jiong Zhou (1)
  Lilla Landeck (2)
  Kai-Hong Zhang (3)
  Zhen Mu (3)
  Chun-Ming Li (1)
  Sui-Qing Cai (1)
  Min Zheng (1)
  
  1. Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China
  2. Department of Dermatology, University of Osnabrueck, Osnabrueck, Germany
  3. Department of Dermatology, Affiliated Hospital, Taishan Medical College, Taishan, China
  
• ISSN：1420-9071

文摘

Psoriasis is a chronic proliferative skin disease and is usually treated with topical glucocorticoids, which act through the glucocorticoid receptor (GR), a component of the physiological systems essential for immune responses, differentiation, and homeostasis. To investigate the possible role of GR in the pathogenesis of psoriasis, normal and psoriatic lesional skin were recruited. Firstly, the immunolocalization of GR in the skin and cultured epidermal keratinocytes were determined by immunofluorescence. In normal skin and cultured human epidermal keratinocytes, intracellular GR is localized in the nuclei, while in psoriatic skin and cultured keratinocytes, GR is in the cytoplasm. Next, we investigated possible factors associated with the cytoplasmic distribution. We found that VEGF and IFN-γ led to impaired nuclear translocation of GR through p53 and microtubule-inhibitor, vincristine, and inhibited nuclear uptake of GR in normal keratinocytes. In addition to dexamethasone, interleukin (IL)-13 was also able to transfer GR into nuclei of psoriatic keratinocytes. Furthermore, discontinuation of dexamethasone induced cytoplasmic retention of GR in normal keratinocytes. In contrast, energy depletion of normal epidermal keratinocytes did not change the nuclear distribution of GR. To confirm our findings in vivo, an imiquimod-induced psoriasis-like skin mouse model was included. IL-13 ameliorated (but vincristine exacerbated) the skin lesions on the mouse. Taken together, our findings define that impaired nuclear translocation of GR is associated with VEGF, IFN-γ, p53, and microtubule. Therapeutic strategies designed to accumulate GR in the nucleus, such as IL-13, may be beneficial for the therapy of psoriasis.